WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

R RESPIRATORY SYSTEM

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.


R01 NASAL PREPARATIONS

Varenicline nasal spray used for dry eye disease is classified in S01XA.


R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE

This group comprises preparations for local treatment in nasal congestion (e.g. sympathomimetics) or for prophylaxis and treatment of allergic rhinitis (e.g. corticosteroids, cromoglicate preparations). Most of the products are nasal drops, nasal sprays or nasal inhalants. Formulations approved for eye, ear and nose are classified in S03.
See also R01B - Nasal decongestants for systemic use, and
R06 - Antihistamines for systemic use.

The DDDs are based on treatment of both nostrils.


R01AB Sympathomimetics, combinations excl. corticosteroids

Combinations with e.g. antibiotics, antihistamines and ipatropium bromide are classified in this group.
This group also includes preparations with two or more sympathomimetics. These combinations are classified in a ranking according to the ATC codes, e.g. substances classified in R01AB01 take precedence over substances classified in R01AB02 etc.
Combinations of phenylephrine and lerimazoline are classified in R01AB01.
Combinations of tetracaine and oxymetazoline for nasal application used as local dental anesthetics are classified in N01BA.


The DDDs are based on the treatment of rhinitis. DDDs are given in volume (i.e. ml). Most of the products classified in this group are combinations with antihistamines. So far, all these products are given a fixed DDD of 0.8 ml.


    ATC code  Name  DDD  U Adm.R Note
    R01AB05 ephedrine    

List of abbreviations

Last updated: 2024-01-26